Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health (NIH)
Grant: K01CA229995
National Institutes of Health (NIH)
Grant: R21HG011506
National Institutes of Health (NIH)
Grant: R21CA260082
National Institutes of Health (NIH)
Grant: R21CA264637
National Institutes of Health (NIH)
Grant: IRG-16-181-57
USC Keck School of Medicine
Grant: Dean's Pilot Grant
USC Center for Genetic Epidemiology
Grant: Pilot grant
National Institutes of Health
Grant: 1K01CA229995-01
Identification and Clinical Validation of Key Transcription Factor Isoforms Linked to Breast and Prostate Cancer Subgroups using Epigenetic Traits
National Institutes of Health
Grant: 5R21CA264637-02
Mapping regulatory elements and chromatin structures in prostate tumor subtypes at single nucleosome resolution
National Institutes of Health
Grant: 1R21CA260082-01
Reversing molecular cancer phenotypes by targeting epigenetic alterations in prostate cancer
National Institutes of Health
Grant: 1R21HG011506-01
Identifying epigenetic states of TADs and targeting using epigenome editing
FWCI
0.55
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals